STAT Plus: Pharma trade group scolds Gilead again for misleading information about a rival HIV drug
For the second time in two years, Gilead was reprimanded for disseminating information that unfairly compared one of its HIV drugs with a rival medicine.
No hay comentarios:
Publicar un comentario